These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24188545)

  • 1. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations for targeted drug delivery.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2013 Jan; 65(1):139-47. PubMed ID: 23280371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems.
    Kozlovskaya L; Stepensky D
    J Control Release; 2013 Oct; 171(1):17-23. PubMed ID: 23831053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and biophase bioavailability and pharmacokinetics of nanoparticulate drug delivery systems.
    Leucuta SE
    Curr Drug Deliv; 2013 Apr; 10(2):208-40. PubMed ID: 23116084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems.
    Maity AR; Stepensky D
    Mol Pharm; 2016 Jan; 13(1):1-7. PubMed ID: 26587994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of drugs to intracellular organelles using drug delivery systems: Analysis of research trends and targeting efficiencies.
    Maity AR; Stepensky D
    Int J Pharm; 2015 Dec; 496(2):268-74. PubMed ID: 26516100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
    Torchilin VP
    Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'IntraCell' plugin for assessment of intracellular localization of nano-delivery systems and their targeting to the individual organelles.
    Sneh-Edri H; Stepensky D
    Biochem Biophys Res Commun; 2011 Feb; 405(2):228-33. PubMed ID: 21219848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
    Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
    Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted intracellular delivery of therapeutics: an overview.
    Rawat A; Vaidya B; Khatri K; Goyal AK; Gupta PN; Mahor S; Paliwal R; Rai S; Vyas SP
    Pharmazie; 2007 Sep; 62(9):643-58. PubMed ID: 17944316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-anchored drugs for delivery into subcellular compartments.
    Rajendran L; Udayar V; Goodger ZV
    Trends Pharmacol Sci; 2012 Apr; 33(4):215-22. PubMed ID: 22385603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications for site-directed molecular imaging agents coupled with drug delivery potential.
    Wang H; Chen X
    Expert Opin Drug Deliv; 2009 Jul; 6(7):745-68. PubMed ID: 19552614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of injectable drug nanocrystals.
    Fuhrmann K; Gauthier MA; Leroux JC
    Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.